H Nina Kim

Summary

Publications

  1. pmc HBV lamivudine resistance among hepatitis B and HIV coinfected patients starting lamivudine, stavudine and nevirapine in Kenya
    H N Kim
    Department of Medicine, University of Washington, Seattle, WA 98104, USA
    J Viral Hepat 18:e447-52. 2011
  2. pmc Effect of acyclovir on HIV-1 set point among herpes simplex virus type 2-seropositive persons during early HIV-1 infection
    H Nina Kim
    Department of Medicine, Schools of Medicine and Public Health, University of Washington, 325 Ninth Avenue, Seattle, WA 98104, USA
    J Infect Dis 202:734-8. 2010
  3. ncbi request reprint Does frequency of genital herpes recurrences predict risk of transmission? Further analysis of the valacyclovir transmission study
    H Nina Kim
    Department of Medicine, Division of Allergy and Infectious Diseases, University of Washington, Seattle, Washington 98104, USA
    Sex Transm Dis 35:124-8. 2008
  4. pmc Prevalence, clinical and virologic outcomes of hepatitis B virus co-infection in HIV-1 positive Kenyan women on antiretroviral therapy
    Summer L Day
    Department of Medicine, University of Washington, Seattle, Washington, United States of America
    PLoS ONE 8:e59346. 2013
  5. pmc Factors Associated With Delayed Hepatitis B Viral Suppression on Tenofovir Among Patients Coinfected With HBV-HIV in the CNICS Cohort
    H Nina Kim
    Department of Medicine, University of Washington, Seattle, WA Departments of Medicine, Epidemiology, University of North Carolina, Chapel Hill, NC Department of Medicine, Johns Hopkins University, Baltimore, MD Department of Medicine, University of Alabama, Birmingham, AL University of California, San Francisco, San Francisco, CA Department of Medicine, Case Western Reserve University, Cleveland, OH Department of Medicine, University of California, San Diego, La Jolla, CA and Department of Medicine, Harvard University and Fenway Community Health, Boston, MA
    J Acquir Immune Defic Syndr 66:96-101. 2014
  6. pmc Independent clinical predictors of impaired response to hepatitis B vaccination in HIV-infected persons
    H Nina Kim
    Department of Medicine, Harborview Medical Center, University of Washington, Seattle, WA, USA
    Int J STD AIDS 19:600-4. 2008
  7. ncbi request reprint Hepatitis C virus activation in HIV-infected patients initiating highly active antiretroviral therapy
    H Nina Kim
    Department of Medicine, University of Washington, Seattle, Washington 98104, USA
    AIDS Patient Care STDS 21:718-23. 2007
  8. ncbi request reprint Optimal timing of routine vaccination in HIV-infected persons
    Heidi M Crane
    Center for AIDS and STD Research, University of Washington, Harborview Medical Center, Box 359931, 325 9th Avenue, Seattle, WA 98104, USA
    Curr HIV/AIDS Rep 6:93-9. 2009
  9. ncbi request reprint Oral herpes simplex virus type 2 reactivation in HIV-positive and -negative men
    H Nina Kim
    Department of Medicine, Division of Allergy and Infectious Diseases, University of Washington, Seattle, 98104, USA
    J Infect Dis 194:420-7. 2006
  10. ncbi request reprint Antiretroviral therapy for HIV-1 vaccine efficacy trial participants who seroconvert
    H Nina Kim
    Departments of Medicine, University of Washington, Seattle, WA, USA
    Vaccine 24:532-9. 2006

Detail Information

Publications13

  1. pmc HBV lamivudine resistance among hepatitis B and HIV coinfected patients starting lamivudine, stavudine and nevirapine in Kenya
    H N Kim
    Department of Medicine, University of Washington, Seattle, WA 98104, USA
    J Viral Hepat 18:e447-52. 2011
    ..Lamivudine resistance can emerge in the setting of incomplete HBV suppression but was infrequently observed among HIV-HBV coinfected patients with low baseline HBV DNA levels...
  2. pmc Effect of acyclovir on HIV-1 set point among herpes simplex virus type 2-seropositive persons during early HIV-1 infection
    H Nina Kim
    Department of Medicine, Schools of Medicine and Public Health, University of Washington, 325 Ninth Avenue, Seattle, WA 98104, USA
    J Infect Dis 202:734-8. 2010
    ..In conclusion, acyclovir suppression during HIV-1 seroconversion and the subsequent 6 months does not affect HIV-1 set point...
  3. ncbi request reprint Does frequency of genital herpes recurrences predict risk of transmission? Further analysis of the valacyclovir transmission study
    H Nina Kim
    Department of Medicine, Division of Allergy and Infectious Diseases, University of Washington, Seattle, Washington 98104, USA
    Sex Transm Dis 35:124-8. 2008
    ..The benefit of suppressive antiviral therapy for reducing the risk of herpes simplex virus (HSV)-2 transmission to sex partners may be enhanced if persons at high risk for transmission can be identified...
  4. pmc Prevalence, clinical and virologic outcomes of hepatitis B virus co-infection in HIV-1 positive Kenyan women on antiretroviral therapy
    Summer L Day
    Department of Medicine, University of Washington, Seattle, Washington, United States of America
    PLoS ONE 8:e59346. 2013
    ..We aimed to determine the prevalence, clinical, and virologic outcomes of chronic HBV infection, including HBV resistance to lamivudine, in a cohort of HIV-1 seropositive Kenyan women on long-term ART...
  5. pmc Factors Associated With Delayed Hepatitis B Viral Suppression on Tenofovir Among Patients Coinfected With HBV-HIV in the CNICS Cohort
    H Nina Kim
    Department of Medicine, University of Washington, Seattle, WA Departments of Medicine, Epidemiology, University of North Carolina, Chapel Hill, NC Department of Medicine, Johns Hopkins University, Baltimore, MD Department of Medicine, University of Alabama, Birmingham, AL University of California, San Francisco, San Francisco, CA Department of Medicine, Case Western Reserve University, Cleveland, OH Department of Medicine, University of California, San Diego, La Jolla, CA and Department of Medicine, Harvard University and Fenway Community Health, Boston, MA
    J Acquir Immune Defic Syndr 66:96-101. 2014
    ..We examined the effect of prior lamivudine (3TC) treatment and other factors on HBV DNA suppression with TDF in a multisite clinical cohort of coinfected patients...
  6. pmc Independent clinical predictors of impaired response to hepatitis B vaccination in HIV-infected persons
    H Nina Kim
    Department of Medicine, Harborview Medical Center, University of Washington, Seattle, WA, USA
    Int J STD AIDS 19:600-4. 2008
    ..033), after adjusting for these other covariates. Our findings underscore the importance of confirming seroconversion after HB vaccination in HIV-infected patients and initiating vaccination early in the course of HIV infection...
  7. ncbi request reprint Hepatitis C virus activation in HIV-infected patients initiating highly active antiretroviral therapy
    H Nina Kim
    Department of Medicine, University of Washington, Seattle, Washington 98104, USA
    AIDS Patient Care STDS 21:718-23. 2007
    ..These observations suggest that flares of hepatitis C in the setting of the immune reconstitution inflammatory syndrome can occur even in those patients who have undetectable serum HCV levels prior to HAART initiation...
  8. ncbi request reprint Optimal timing of routine vaccination in HIV-infected persons
    Heidi M Crane
    Center for AIDS and STD Research, University of Washington, Harborview Medical Center, Box 359931, 325 9th Avenue, Seattle, WA 98104, USA
    Curr HIV/AIDS Rep 6:93-9. 2009
    ..However, risks of delaying vaccination include that the patient may be exposed to the pathogen or lost to follow-up before vaccination. We review recent studies on the timing of routine vaccination of HIV-infected individuals...
  9. ncbi request reprint Oral herpes simplex virus type 2 reactivation in HIV-positive and -negative men
    H Nina Kim
    Department of Medicine, Division of Allergy and Infectious Diseases, University of Washington, Seattle, 98104, USA
    J Infect Dis 194:420-7. 2006
    ..Previous studies using viral cultures rarely reported herpes simplex virus type 2 (HSV-2) isolation from the mouth. We sought to characterize oral HSV-2 shedding as detected by HSV DNA polymerase chain reaction among HSV-2-seropositive men...
  10. ncbi request reprint Antiretroviral therapy for HIV-1 vaccine efficacy trial participants who seroconvert
    H Nina Kim
    Departments of Medicine, University of Washington, Seattle, WA, USA
    Vaccine 24:532-9. 2006
    ..A standardized HAART protocol for HIV-1 vaccine efficacy trial participants who become HIV-infected is essential to the evaluation of CTL-based HIV-1 vaccines on the natural history of HIV-1 infection...
  11. pmc Offering an American graduate medical HIV course to health care workers in resource-limited settings via the Internet
    Michael H Chung
    Department of Global Health, University of Washington, Seattle, WA, USA
    PLoS ONE 7:e52663. 2012
    ..It is not known whether HCWs are interested in these online courses, whether they can perform as well as matriculated students, or whether such courses are educationally or practically relevant...
  12. ncbi request reprint Superficial hepatic capsular lesions in a systemically ill young woman
    Lindy S Klaff
    Department of Medicine, Harborview Medical Center, University of Washington, 325 Ninth Avenue, Seattle, WA 98104, USA
    Sex Transm Dis 34:139-40. 2007
  13. ncbi request reprint Antiretroviral therapy: a primer for dermatologists
    H Nina Kim
    Division of Allergy and Infectious Diseases, University of Washington School of Medicine, 325 Ninth Avenue, Seattle WA 98104, USA
    Dermatol Clin 24:537-47, vii. 2006
    ....